MedTrace Logo

Adipose-derived Stem Cells to Treat Chronic Wounds.

NCT05797688 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2023-04-04

No results posted yet for this study

Summary

The goal of this study is to determine whether autologous, adipose-derived regenerative cells improve the healing of chronic wounds. Ten patients will undergo fat harvest and peri-wound injection of the isolated cells in addition to the standard of care for the treatment of their chronic wound. Wound healing will be followed over 24 weeks.

Conditions

  • Wound of Skin

Interventions

DEVICE

The Celution System

The Celution System will isolate regenerative cells, including stem cells, from fat harvested from the treatment patients.

Sponsors & Collaborators

  • Cytori Therapeutics

    collaborator INDUSTRY

  • Winthrop University Hospital

    lead OTHER

Principal Investigators

  • Harold Brem, MD · Winthrop University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-07-31
Completion
2017-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05797688 on ClinicalTrials.gov